23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals

fastcompany.com/91336911/23andme-sensitive-dna-genetic-data-sold-to-regeneron-biotech

Genetic data was on the auction block, and a U.S. biotech company ponied up the cash.
New York-based Regeneron Pharmaceuticals announced on Monday that it has purchased DNA testing company 23andMe through a bankruptcy auction for a total of $256 million.
The deal includes most of the…

This story appeared on fastcompany.com, 2025-05-19 15:25:00.
The Entire Business World on a Single Page. Free to Use →